Burning Rock Biotech Limited ( BNR) - Stock Earnings
BNR Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 17, 2026, midnight | — / — | — | — / — | — |
BNR Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -2.4 million USD | 18.5 million USD |
| 2025Q4 | -2.2 million USD | 17.8 million USD |
| 2026Q1 | -2.5 million USD | 15.6 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
BNR Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -92.3 million USD | 75.9 million USD |
| 2024 | -47.5 million USD | 70.7 million USD |
| 2025 | -7.9 million USD | 77.1 million USD |
| 2025 Est. | — | — |
BNR
Price: $11.82
52 week price:
Earnings Per Share: -0.83 USD
Exchange: NGM
Sector: Healthcare
Industry: Diagnostics & Research
Country: China
Volume: 139800
Market Capitalization: 17.2 million